You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 123 No. 10, October 1997 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Chronic Otitis Media Treated Topically With Ciprofloxacin or Tobramycin

Milo, MD; Alexander Brodsky, MD; Jacob Ben-David, MD; Isaac Srugo, MD; Josef Larboni, MSc; Ludwig Podoshin, MD

Arch Otolaryngol Head Neck Surg. 1997;123(10):1057-1060.


Abstract

Objective
To evaluate the efficacy of ciprofloxacin compared with tobramycin and placebo ear drops in the treatment of chronic suppurative otitis media without cholesteatoma.

Design
Sixty ears (in 51 patients) were randomly divided into 3 treatment groups: ciprofloxacin hydrochloride, tobramycin, and placebo interventions.

Setting
The otolaryngology department of a university teaching hospital.

Intervention
All ears were treated topically for 3 weeks.

Main Outcome Measures
Each patient received a small, numbered bottle and was instructed to instill 5 drops 3 times daily for 3 weeks. The final clinical and bacteriologic assessment was made after 3 weeks.

Results
The organism most commonly isolated from the ear discharge was Pseudomonas aeruginosa. Its sensitivity to ciprofloxacin and tobramycin was 94.2% and 70.6%, respectively. The clinical response was 78.9%, 72.2%, and 41.2% in the ciprofloxacin, tobramycin, and placebo groups, respectively. The bacteriologic response rate was 66.7% for the ciprofloxacin and tobramycin groups and 20% for the placebo group. Treatment with ciprofloxacin ear drops seemed to be as effective as treatment with tobramycin.

Conclusion
While the lack of ototoxicity of ciprofloxacin was not tested in our study, this treatment may be considered as a potential topical therapy for cases of chronic suppurative otitis media.

Arch Otolaryngol Head Neck Surg. 1997;123:1057-1060



Author Affiliations

From the Departments of Otolaryngology—Head and Neck Surgery (Drs Fradis, Brodsky, Ben-David, and Podoshin), Microbiology (Dr Srugo), and Pharmacy (Mr Larboni), Bnai Zion Medical Center; and The Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology (Drs Fradis, Ben-David, Srugo, and Podoshin), Haifa, Israel.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Topical Ciprofloxacin/Dexamethasone Otic Suspension Is Superior to Ofloxacin Otic Solution in the Treatment of Children With Acute Otitis Media With Otorrhea Through Tympanostomy Tubes
Roland et al.
Pediatrics 2004;113:e40-46.
ABSTRACT | FULL TEXT  

Evaluation of Topical Povidone-Iodine in Chronic Suppurative Otitis Media
Jaya et al.
Arch Otolaryngol Head Neck Surg 2003;129:1098-1100.
ABSTRACT | FULL TEXT  

Treatment of Chronic Suppurative Otitis Media With Topical Tobramycin and Dexamethasone
Alper et al.
Arch Otolaryngol Head Neck Surg 2000;126:165-173.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.